ENETF yields 400000.00% · MRK yields 2.76%● Live data
📍 ENETF pulled ahead of the other in Year 1
Combined, ENETF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ENETF + MRK for your $10,000?
Ethernity Networks Ltd. provides technology solutions for telecom, mobile, security, and data center markets in Asia, Europe, Israel, and the United States. The company develops and delivers data processing technology and solutions for carrier Ethernet switching, including broadband access, mobile backhaul, carrier Ethernet demarcation, and data centers. It provides ENET flow processors for telco/cloud network; ACE-NIC40 SmartNIC, an open flow enabled software acceleration NIC; ACE-NIC40 SmartNIC, an open flow enabled software acceleration NIC; ACE-NIC50 SmartNIC, which offers 10/25G Ethernet connectivity and field-programmable gate array (FPGA) acceleration; ACE-NIC100 SmartNIC that provides flexible 10/25/40/100G Ethernet connectivity and programmable FPGA acceleration; ENET UEP-60, a programmable routing appliance for 5G, OpenRAN, and Network Edge; and ACE-NIC100 SmartNIC that provides flexible 10/25/40G/100G Ethernet connectivity and programmable FPGA acceleration. The company also offers ENET network appliances, such as ENET UEP-20 universal edge platform and ENET UEP-60 universal edge platform. In addition, it provides FPGA based networking and security solutions to telco/cloud equipment manufacturers and system integrators. The company was formerly known as Neracore Ltd. and changed its name to Ethernity Networks Ltd. in August 2004. Ethernity Networks Ltd. was incorporated in 2003 and is headquartered in Airport City, Israel.
Full ENETF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.